Skip to main content
OpenTrials

Clinical trial condition

Anus Diseases

Explore clinical trials studying Anus Diseases. Study availability and eligibility vary by location and protocol.

260 public trials 58 recruiting studies
Refine in advanced search Browse all conditions

Anus Diseases trial results

Active, Not Recruiting

A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males

NCT06866574

Conditions
Anal Cancer, Anal Intraepithelial Neoplasia, Anus Diseases, +34 more
Locations
  • Fujian Provincial Center for Disease Control and Prevention Fuzhou, Fujian, China
  • Sichuan Provincial Center for Disease Control and Prevention Chengdu, Sichuan, China
  • Yunnan Provincial Center for Disease Control and Prevention Kunming, Yunnan, China
  • Zhejiang Provincial Center for Disease Control and Prevention Hangzhou, Zhejiang, China
View Trial Details
Active, Not Recruiting

Anti-PD-1 and mDCF Followed by Chemoradiotherapy in Patients With Stage III Squamous Cell Anal Carcinoma.

NCT04719988

Conditions
Anus Diseases, Anus Neoplasms, Colorectal Neoplasms, +11 more
Locations
  • Centre Hospitalier Universitaire de Besançon Besançon, France
  • Centre georges-François Leclerc Dijon, France
  • Hôpital Franco-Britannique Levallois-Perret, France
  • Centre Léon Bérard Lyon, France
View Trial Details
Active, Not Recruiting

A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males

NCT06465914

Conditions
AIN1, AIN2, AIN3, +45 more
Locations
  • Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention Nanning, Guangxi, China
  • Hunan Center for Disease Control and Prevention Changsha, Hunan, China
  • Shanxi Provincial Disease for Control and Prevention Taiyuan, Shanxi, China
  • Sichuan Center for Disease Control and Prevention Chengdu, Sichuan, China
View Trial Details
Active, Not Recruiting

Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. a Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group

NCT04230759

Conditions
Anal Cancer, Anal Cancer Stage II, Anal Cancer Stage III, +14 more
Locations
  • Univeritätsklinik für Strahlentherapie-Radioonkologie Graz, Austria
  • Institut für Radioonkologie und Strahlentherapie Darmstadt, Germany
  • Klinik und Poliklinik für Strahlentherapie und Radioonkologie Dresden, Germany
  • Klinik für Strahlenheilkunde, Universitätsklinikum Freiburg Freiburg im Breisgau, Freiburg, Germany
View all 25 locations
View Trial Details

Related conditions